Mark Maxfield to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Mark Maxfield has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.607
-
Reddington H, Emmerick I, Diaz Collante J, Maini A, Kanzaria R, Crawford A, Phillips W, Maxfield M, Uy K, Lou F. Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer. PLoS One. 2026; 21(6):e0349231.
Score: 0.207
-
Diaz Collante J, Crawford A, Reddington H, Markel A, Epstein M, Gray C, Lou F, Phillips W, Maxfield M, Uy K, Emmerick I. National trends in lung cancer stage, treatment, and time to treatment initiation after a major healthcare disruption (NCDB 2014-2022). J Cancer Policy. 2026 Jun; 48:100724.
Score: 0.203
-
Reddington H, Ballinger Z, Guart J, Emmerick I, Crawford A, Maxfield M, Uy K, Lou F. National adoption of robotic-assisted thoracoscopic surgery for oncologic lung resections. J Robot Surg. 2025 Sep 04; 19(1):557.
Score: 0.197